Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | REX | GFR |
|---|---|---|
| Price | $43.41 | $5.99 |
| Change today | ▲ 0.09% | ▲ 3.28% |
| Market cap | $1.44B | $1.44B |
| Return, 3 months | -5.8% | +8.1% |
| Return, year to date | +34.3% | +25.8% |
| Return, 1 year | +35.6% | +24.5% |
| P/E (TTM) | 11.9 | -23.9 |
| P/B | 2.1 | 1.8 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 53 | 47 |
| 30-day volatility | 29.5% | 43.3% |
| Max drawdown, 1 year | -19.9% | -21.3% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
